Researchers have discovered a rare new type of diabetes that affects babies early in life. The condition is caused by changes ...
The TellDx CTC iChip platform enables high-efficiency isolation of intact circulating tumor cells without reliance on cell size or epithelial markers. This unbiased approach is particularly well ...
The blood-brain and blood-retinal barriers are protective systems that prevent harmful substances from entering the brain and ...
How much vitamin C you need per day depends on your age, sex, pregnancy and lactation status, and if you smoke. Here are the guidelines and general limits.
The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...
This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.
CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...
aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...
A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
Folic acid, also known as vitamin B9, is an important B-vitamin with many vital functions in the human body. It was ...
Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera
Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera: Osaka, Japan Wednesday, January 7, 2026, 17:00 Hrs [IST] Takeda, focused on c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results